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Tumour hypoxia is associated with poor patient prognosis and therapy resistance. A unique
transcriptional response is initiated by hypoxia which includes the rapid activation of
numerous transcription factors in a background of reduced global transcription. Here, we
show that the biological response to hypoxia includes the accumulation of R-loops and the
induction of the RNA/DNA helicase SETX. In the absence of hypoxia-induced SETX, R-loop
levels increase, DNA damage accumulates, and DNA replication rates decrease. Therefore,
suggesting that, SETX plays a role in protecting cells from DNA damage induced during
transcription in hypoxia. Importantly, we propose that the mechanism of SETX induction in
hypoxia is reliant on the PERK/ATF4 arm of the unfolded protein response. These data not
only highlight the unique cellular response to hypoxia, which includes both a replication
stress-dependent DNA damage response and an unfolded protein response but uncover a
novel link between these two distinct pathways.
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The microenvironment of the majority of solid tumours ischaracterised by regions of low oxygen (hypoxia), whichresult from abnormal vasculature and increased oxygen
demand. Tumour hypoxia plays a pivotal role in tumorigenesis
and has been associated with increased aggressiveness, metastasis,
resistance to radiotherapy, and poor patient prognosis1. The level
of hypoxia associated with radiation resistance (<0.13% O2) is
characterised by a rapid induction of replication stress, which is
defined as the slowing or stalling of replication forks. We have
attributed hypoxia-induced replication stress to decreased
nucleotide availability2–4. Hypoxia-induced replication stress
leads to the induction of an ATR- and ATM-dependent DNA
damage response (DDR), although hypoxia-induced replication
stress is insufficient to induce ATM-mediated signalling and
increased levels of heterochromatic histone marks, notably
H3K9me3 are also required5–7. Importantly, both hypoxia-
induced ATR and ATM activity occur in the absence of detect-
able DNA damage8. Transcriptional stress, defined as global
repression of RNA synthesis, has also been identified in the
hypoxic conditions which lead to a DDR9.
R-loops are 3–stranded nucleic acid structures that are linked
to transcription and can contribute to replication stress10. R-loops
are comprised of an RNA/DNA hybrid and a displaced single-
stranded DNA (ssDNA), for recent reviews see11–13. R-loops
form within the genome at actively transcribed genes pre-
ferentially occurring at gene promoters and terminators. R-loop
homoeostasis is regulated through several pathways including
mRNA processing, RNA modifications, DNA topology, single-
stranded DNA-binding proteins and by specialised R-loop pro-
cessing enzymes such as RNase H, RNA/DNA hybrid helicases
and DNA nucleases14–17. R-loops regulate gene expression but
can also lead to genome instability, which is particularly apparent
in cells with deficiencies in R-loop processing and binding factors,
including for example BRCA118–22. Recently, a role for R-loops
has been described in the regulation of RNA polymerase I (Pol I)
activity by RNA polymerase II (Pol II)23. R-loops have not been
studied in the context of hypoxia however, hypoxia initiates a
significant change to cellular transcription suggesting there may
be an impact on R-loop formation and resolution9,24. Despite a
reduction in global levels of transcription, a number of tran-
scriptional pathways are induced in hypoxia including the
hypoxia-inducible factors (HIF1-3), p53 and those initiated by the
unfolded protein response (UPR)25–27. The UPR is an ER stress-
response pathway that leads to global translation inhibition while
upregulating selective genes including those involved in protein
folding, redox homoeostasis and protein degradation28. In con-
trast to the DDR, which is activated by ssDNA in hypoxia, the
UPR is activated by misfolded proteins. Notably, the DNA repair
pathways, including critical R-loop associated factors such as
BRCA1 and Rad51, have been shown to be repressed through a
variety of mechanisms in response to hypoxia29–31.
Senataxin (SETX) is a putative RNA/DNA helicase that can
facilitate transcription termination and gene transcription of a
subset of genes32–36. The yeast homologue of SETX, Sen1, was
shown to be involved in transcription-coupled repair and protect
cells from transcription-associated recombination37–39. In addi-
tion, Sen1 has been shown to act at the replication fork and
facilitate replication at highly transcribed genes40. SETX has also
been linked to R-loops at transcription–replication collisions and
to participate in the antiviral response39,41. Mutations in SETX
have been associated with two neurodegenerative diseases, ataxia
with oculomotor apraxia type 2 (AOA2) and amyotrophic lateral
sclerosis type 4 (ALS4)42,43.
The role of R-loops and factors involved in R-loop processing
including RNA/DNA helicases have not been investigated in
response to hypoxia. We show that in hypoxia, which includes
transcriptional and replication stress, R-loops increase. The
majority of the factors investigated associated with R-loops were
found to be repressed with the notable exception of SETX, which
was induced in hypoxia, prompting us to focus on the role of
SETX in hypoxia. We found that the loss of SETX leads to an
accumulation of R-loops, and that hypoxia-induced SETX pro-
tected cells from replication stress, transcription-dependent DNA
damage and apoptosis. Most importantly, hypoxia-induced SETX
was dependent on the PERK branch of the UPR, suggestive of a
link between the UPR and replication stress in hypoxia.
Results
SETX is induced in an oxygen-dependent manner. Exposure to
hypoxia (<0.1% O2) led to the rapid accumulation of RPA foci
and pan-nuclear γH2AX in the absence of 53BP1 foci. Impor-
tantly, the cells that had pan-nuclear γH2AX also had RPA foci
which indicate a replication stress-dependent DDR in the absence
of detectable DNA damage (Fig. 1a, b and Supplementary
Fig. 1a). This hypoxia-induced DDR occurred in a background of
decreased global transcription rates as shown by quantification of
5-ethynyluridine (5′EU) incorporation (Fig. 1c, d and Supple-
mentary Fig. 1b). In these same conditions (<0.1% O2), the
transcript levels of a number of R-loop processing factors
including RNase H1, RNase H2B, PIF1, DHX9, RTEL1, and
AQR, were significantly repressed, in contrast, SETX was upre-
gulated (Fig. 1e). As SETX has not previously been shown to be
stress-responsive at the transcriptional level, we verified that
hypoxia-mediated induction of SETX was evident in a number of
cell lines (Supplementary Fig. 1c–e). SETX protein levels were
also upregulated in hypoxia in the cell lines tested (Fig. 1f–h). To
determine oxygen dependency, we compared expression levels in
<0.1% O2 to 2% O2 and found that SETX was specifically induced
at <0.1% O2 (Fig. 1i). Next, we looked for evidence of links
between hypoxia and SETX in cancer patients, using The Cancer
Genome Atlas (TCGA) colorectal and lung cancers datasets.
Here, we compared SETX expression with both, a validated
hypoxia signature and with a group of genes that, like SETX, we
have previously shown are induced at <0.1% O2 but not 2%
O225,44. As we saw no indication of SETX induction in 2% O2, we
were not surprised to find that SETX expression did not correlate
with the hypoxia signature (Supplementary Fig. 1f). However, in
agreement with the SETX induction at <0.1% O2, SETX expres-
sion showed a positive correlation with the group of genes we
have identified as induced at <0.1% O2 (Fig. 1j)25. Therefore, it
seems likely that SETX expression is increased in patient samples
with tumours experiencing hypoxia-induced replication stress,
lending further support to our novel finding that SETX is induced
in an oxygen-dependent manner.
Loss of SETX leads to changes in gene expression in hypoxia.
SETX has been suggested to affect Pol II binding at certain genes
and to facilitate transcriptional termination of a number of
genes34,35,45. Under normoxic conditions SETX knockdown led
to a significant decrease in 5′EU incorporation and given that the
majority of transcriptional output is rRNA, this agrees with the
recent report demonstrating that SETX supports rRNA
transcription23. In hypoxia where transcription rates are reduced,
there was a modest, further decrease in 5′EU incorporation upon
SETX depletion (Fig. 2a). A previous study identified changes in
the expression of 36 genes in response to SETX depletion, and 60
genes changing in a SETX-dependent manner in response to viral
infection41. We carried out RNA-seq, which confirmed that SETX
was induced in hypoxia by approximately 3-fold and found that
SETX depletion affected a small subset of genes (17 increasing
and 48 decreasing) in normoxia, and of these genes, 5 were
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previously identified as regulated in a SETX-dependent manner.
In contrast, SETX depletion in hypoxia caused 341 genes to
increase and 256 genes to decrease in expression (Fig. 2b). These
changes were also validated by RT-qPCR (Fig. 2c). We asked
whether the differentially expressed genes shared any common
features by gene ontology analysis and found that approximately
20% of genes upregulated in SETX-depleted hypoxic cells were
involved in rRNA processing, nucleolus and ribosome biogenesis
(Supplementary Fig. 2a). In addition, hypoxia-induced genes that
had increased expression in SETX-depleted cells had a slightly
shorter gene length compared to the hypoxia-induced genes that
were unaffected or had decreased expression upon SETX deple-
tion (Supplementary Fig. 2b). Differentially expressed genes had
similar numbers of exons, G4 quadruple structures or GC per
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cent (Supplementary Fig. 2c–e). Next, we investigated the pre-
valence of R-loop forming sequences (RLFS) in the genes altered
in a SETX-dependent manner using a validated prediction
tool46,47 There was no difference in the RLFS density between up
and downregulated genes, however, both gene sets have sig-
nificantly more RLFS than genes randomly selected from all
protein-coding genes (Fig. 2d, e). Together these analyses suggest
that SETX has a role in regulating gene expression which is
hypoxia specific and is likely linked to a role in R-loop resolution
as the affected genes all have high levels of RLFS.
R-loops accumulate in response to hypoxia. To determine the
impact of loss of SETX in hypoxia on R-loops, we used the S9.6
antibody, which specifically recognises RNA/DNA hybrids. The
nuclear intensity of S9.6 increased in response to hypoxia and
importantly, this was ablated by treatment with RNase H, an
endonuclease that degrades the RNA component of R-loops
(Fig. 3a, b). A slot blot using the S9.6 antibody in normoxic and
hypoxic conditions also demonstrated an increase in S9.6 staining
in hypoxia (Supplementary Fig. 3a). Importantly, an orthogonal
assay using the catalytic-dead mutant RNase H1D210N to visualise
R-loops also determined an accumulation in R-loops in response
to hypoxia (Fig. 3c, d)48,49. Together, these findings demonstrate
that R-loop levels increase in response to hypoxia. To further
investigate this surprising finding, we asked how decreasing R-
loops in hypoxia through overexpression of RNase H1 would
impact the biological response to hypoxia. R-loops can lead to a
localised increase in H3K9me2 and to replication stress, both of
which are part of the hypoxic response50,51. Overexpression of
RNase H1 leads to a decrease in H3K9me2 (3-fold) and
H3K9me3 (3-fold) in hypoxia but had no significant impact on
the levels of these marks in normoxic conditions (Fig. 3e). As
expected, exposure to hypoxia led to phosphorylation of RPA and
Chk1, confirming replication stress. However, cells over-
expressing RNase H1 showed decreased levels of hypoxic RPA
and Chk1 phosphorylation, and RPA foci in comparison to the
mock-treated cells (Fig. 3f, g). It has been previously shown that
the combination of replication stress and a heterochromatic
environment lead to an ATM-dependent DDR in hypoxia5.
Overexpression of RNase H1 led to a decrease in ATM signalling,
including reduced KAP1-S824, p53-S15, and γH2AX in hypoxia
(Fig. 3h). Together, these data demonstrate that overexpression of
RNase H1 significantly impacts both replication stress and the
DDR in hypoxia (<0.1% O2) supporting that the biological
response is affected by the accumulation of R-loops in hypoxia.
Loss of SETX leads to DNA damage and decreased viability in
hypoxia. Next, we investigated the role of SETX and found that
siRNA mediated depletion of SETX led to an increase in the levels
of R-loops in both normoxia and hypoxia, and again, this increase
was ablated with RNase H treatment (Fig. 4a and Supplementary
Fig. 3b–f). As R-loops can contribute to replication stress, we
asked if SETX had a role to play in replication in hypoxia.
Depletion of SETX led to a significant increase in stalled repli-
cation forks in normoxic conditions (Supplementary Fig. 3g).
However, no changes were detected in hypoxic conditions, likely
because hypoxia alone induced high levels of stalled forks (Sup-
plementary Fig. 3h). However, SETX depletion also decreased
replication rates and this was more significant in hypoxic com-
pared to normoxic conditions (Fig. 4b and Supplementary Fig. 3i,
j). Given that unresolved R-loops have been associated with DNA
damage, we asked whether depleting SETX would lead to DNA
damage in hypoxia. As expected, there was no increase in DNA
damage in hypoxia but upon SETX depletion there was a sig-
nificant increase in DNA damage as determined by increased
numbers of cells with 53BP1 foci (Fig. 4c and validated with a
second siRNA Supplementary Fig. 4a). To test whether the DNA
damage observed in the SETX-depleted hypoxic cells was linked
to transcription, we treated cells with dichloro-beta-D-ribofur-
anosylbenzimidazole (DRB), which inhibits Pol II-mediated
transcription. DRB rescued the DNA damage observed in the
SETX-depleted hypoxic cells suggesting that the damage observed
in SETX-depleted hypoxic cells was transcription-dependent
(Fig. 4c). We confirmed that DRB did not rescue DNA damage
non-specifically by demonstrating that DRB did not rescue
Adriamycin-induced DNA damage (Supplementary Fig. 4b). It
should be noted that by inhibiting transcription, DRB led to a
decrease in R-loop levels, suggesting that SETX may be protecting
the hypoxic cells from co-transcriptional R-loop associated DNA
damage (Supplementary Fig. 4c–e). Interestingly, the DNA
damage observed in SETX-depleted hypoxic cells occurred in
non-S-phase cells, suggesting that the role of SETX in hypoxia is
not to mediate transcription–replication conflicts (Fig. 4D). DNA
damage, if unrepaired, can lead to increased apoptosis and
reduced survival. In hypoxia, SETX depletion led to decreased
colony survival when compared to control cells, suggesting that
SETX function contributes to hypoxic cell viability (Fig. 4e).
SETX depletion also led to a significant increase in apoptosis
compared to the control cells specifically in hypoxia and again,
this was found to be transcription-dependent as the addition of
DRB rescued the apoptosis induced by SETX loss (Fig. 4f and
Fig. 1 SETX is induced in an oxygen-dependent manner. a RKO cells were exposed to <0.1% O2 for 0, 3, 6 and 18 h or to NCS (200 ng/µL) for 6 h. Cells
were fixed and stained for ɣH2AX, RPA and 53BP1. The percentage of cells stained with each marker in each condition is shown, individual data points
represent the average in separate fields of view. More than 100 cells were counted in each condition. A representative plot (of 2 independent) experiments
is shown. b Representative images from a (scale bar: 5 μm). NCS= neocarzinostatin. c RKO cells were exposed to <0.1% O2 for 0, 6 and 18 h with 5′EU
(0.5 mM) added for the final 6 h. Representative of 3 independent experiments (n= 3). Each dot represents a cell and a minimum of 100 cells was imaged
per treatment. One-way ANOVA Tukey’s multiple comparisons test was used, ****p < 0.0001. d Representative images from c (scale bar: 5 μm). e RKO
cells were exposed to <0.1% O2 for 6 h followed by RT-qPCR for the mRNAs indicated relative to the normoxic control. The dashed line indicates normoxic
expression levels. One-way ANOVA Dunnett’s multiple comparisons test was used: RNase H1 (p= 0.0162), RNase H2B (p= 0.0042), PIF1 (p < 0.0001),
AQR (p= 0.0207), DHX9 (p= 0.0010), RTEL1 (p= 0.0046), SETX (p < 0.0001). f RKO cells were treated for 0, 3, 6, and 18 h of <0.1% O2. The levels of
SETX, HIF1α and RPA are shown. β-actin is the loading control. g A549 cells were treated for 0, 3, 6, and 18 h of <0.1% O2. The levels of SETX, HIF1α, and
p53 are shown. β-actin is the loading control. h HCT116 cells at 0, 4, 8, and 12 h of treatment with <0.1% O2. The levels of SETX, HIF1α, p53 and the loading
control β-actin, are shown. i A549 cells were exposed to hypoxia, 2% O2 or <0.1% O2 for the times indicated and the relative mRNA levels of SETX
determined. Two-way ANOVA was used (p < 0.0001). j To examine SETX expression against tumour-associated hypoxia-induced p53 activity (referred to
as hypoxia-induced p53 targets), raw data for each sequenced gene were rescaled to set the median equal to 1, and hypoxic p53 targets were determined
by quantifying the median expression of 6 p53 target genes associated with hypoxia-induced p53 activity (encoding BTG2, CYFIP2, INPP5D, KANK3,
PHLDA3, and SULF2)25. Correlations and statistical significance were determined by calculating Spearman’s rho rank correlation coefficient (r) and two-
tailed P-value using Hmisc package in RStudio: Lung squamous cell carcinoma (p= 0.0034), lung adenocarcinoma (p < 0.0001), Colorectal (p= 0.0003).
a–i Data from three independent experiments (n= 3), mean ± standard error of the mean (SEM) are displayed unless otherwise indicated.
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Supplementary Fig. 4f). Taken together, SETX protects hypoxic
cells from transcription linked DNA damage and apoptosis.
SETX upregulation is dependent on the UPR. SETX has not
previously been shown to be stress-responsive, to investigate the
mechanism of SETX induction in hypoxia, A549 cells were used
as these showed the most robust transcriptional induction of
SETX in hypoxia. Multiple candidate transcription factors are
active at the oxygen level (<0.1% O2) shown to induce SETX,
including HIF, p53 and those involved in the UPR (ATF3, ATF4,
ATF5 and CHOP) (Supplementary Fig. 5a, b). Given that SETX
was not induced at 2% O2 where HIF is active, and SETX
expression did not correlate with a hypoxia signature, it seemed
unlikely that SETX induction was dependent on HIF. However, to
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formally test this, we depleted HIF1α and asked whether this
affected SETX induction in hypoxia. As expected SETX induction
in hypoxia was not affected by HIF1α siRNA in contrast to the
control gene VEGF, confirming that SETX is not induced by
HIF1α in hypoxia (Supplementary Fig. 5c, d). We also demon-
strated that SETX expression was not induced with the hypoxia
mimetic desferrioxamine (DFO) and 2% O2, which lead to HIF
stabilisation (Supplementary Fig. 5e, f). Next, we found that SETX
induction in hypoxia was not affected by p53 siRNA, suggesting
that p53 signalling does not contribute to SETX induction in
hypoxia (Fig. 5a and Supplementary Fig. 5g). In support of this
conclusion, we and others have found no evidence of a functional
p53 response element in the SETX promoter52. Next, we inves-
tigated whether SETX induction could be linked to the UPR.
Predicted binding sites were identified for the UPR transcription
factor ATF4 in the GeneHancer identifier GH09J132349 corre-
sponding to the SETX promoter region. We depleted ATF4 using
siRNA and demonstrated that ATF4 is responsible for the
induction of SETX in hypoxia (Fig. 5b and Supplementary
Fig. 6a). The transcript levels of the ATF4 target CHOP were
tested in parallel to confirm ATF4 knockdown (Supplementary
Fig. 6b). ChIP was used to determine direct ATF4-mediated
transactivation of SETX and demonstrated that ATF4 was enri-
ched at the SETX promoter specifically in hypoxia (Fig. 5c). ATF4
enrichment at the CHOP gene was used as a positive control
(Supplementary Fig. 6c). To further investigate whether SETX is a
UPR target, we exposed cells to a range of stresses including
tunicamycin and thapsigargin, both of which are known to induce
the UPR, and found that both led to a significant increase in
SETX mRNA similar to the induction observed in hypoxia
(<0.1% O2) (Fig. 5d, Supplementary Fig. 6d). Consistent with this,
SETX was found to be upregulated in published RNA sequencing
datasets upon tunicamycin or thapsigargin treatment53,54. We
considered that SETX might be responsive to replication stress
and that tunicamycin and thapsigargin could induce replication
stress. However, hydroxyurea (Hu) did not induce SETX (Fig. 5d)
and we saw no evidence of replication stress-induced in response
to either thapsigargin or tunicamycin (Fig. 5e and Supplementary
Fig. 6e, f). The data presented so far suggest that the hypoxia-
induced UPR reduces replication stress through PERK/ATF4-
dependent induction of SETX. To interrogate the relationship
between the UPR and replication stress we made use of agents
which, unlike hypoxia, induce either a UPR or replication stress
but not both (Fig. 5e). Cells were treated with Hu, to induce
replication stress, with or without thapsigargin and the number of
cells with RPA foci determined in each condition. The number of
cells with Hu-induced RPA foci were significantly reduced by
thapsigargin treatment (Fig. 5f, g). Importantly, we determined
that this was not due to decreased expression of RPA which could
have occurred due to reduced translation rates induced by the
UPR (Supplementary Fig. 6g). Signalling to ATF4 in hypoxia is
primarily mediated by the protein kinase R (PKR)-like endo-
plasmic reticulum kinase (PERK)55,56 which led us to the
hypothesis that the reduction in Hu-induced replication stress
observed in the presence of thapsigargin could be PERK-
mediated. In support of this hypothesis, we demonstrated again
that adding thapsigargin to Hu-treated cells reduced RPA phos-
phorylation (Fig. 5h) but that this effect was abrogated if a PERK
inhibitor GSK2606414 (PERKi) was also included (Fig. 5i).
The UPR is linked with replication stress in hypoxia. As
expected, depleting PERK using siRNA abrogated the hypoxia-
mediated induction of SETX (Fig. 6a and Supplementary Fig. 6h).
In addition, PERKi led to a significant decrease in SETX mRNA
levels in hypoxia as compared to the control cells (Supplementary
Fig. 6i, j). We also verified that pre-treating cells with PERKi
abrogated thapsigargin-mediated SETX induction, again
demonstrating that SETX induction during the UPR is down-
stream of PERK (Fig. 6b and Supplementary Fig. 6k).
Since SETX depletion led to an increase in R-loops, we
hypothesised that PERK depletion would have a similar effect. To
test our hypothesis, we used both S9.6 and RNaseH1D210N to
determine changes in R-loop levels with siRNA to PERK or
PERKi. siRNA mediated PERK depletion and PERKi led to an
increase in R-loop levels in hypoxia using both detection methods
suggesting that, like SETX, PERK signalling negatively regulates
R-loops in hypoxia (Fig. 6c and Supplementary Fig. 7a–e). As
SETX depletion led to an increase in transcription-dependent
DNA damage, we asked whether PERK inhibition showed a
similar effect. Akin to SETX depletion, PERK inhibition led to an
accumulation of DNA damage which was more significant under
hypoxic conditions and dependent on transcription (Fig. 6d).
Together, these data suggest a role for PERK in reducing
replication stress and DNA damage in hypoxia. In agreement
with this conclusion, when PERK was inhibited in hypoxia we
saw an increase in both phosphorylations of p53 and RPA
indicating an exacerbation of the DDR and replication stress
(Fig. 6e). To investigate further, we determined the number of
Fig. 2 Gene expression changes in response to the loss of SETX. a RKO control cells or SETX-depleted cells were exposed to 21% and <0.1% O2 for 6 h in
the presence of 5′EU. Cells were fixed, stained and quantified for 5′EU (0.5 mM) incorporation. Cells treated with siRNA to SETX are shown in green. Data
from three independent experiments (n= 3) where each dot represents a cell and a minimum of 100 cells were imaged per treatment. One-way ANOVA
Tukey’s multiple comparisons test was used: ****p < 0.0001, *p= 0.0146. b RNA-seq results comparing RKO cells treated with control siRNA or SETX
siRNA in 21% O2 (Norm, grey) and <0.1% O2 (Hyp). Genes with a decreased expression upon SETX depletion in hypoxia shown in red, and genes with an
increased expression upon SETX depletion in hypoxia shown in blue. RNA-seq was carried out in 3 biological replicates (n= 3). c RKO cells were treated
with control siRNA or SETX siRNA and exposed to <0.1% O2 for 6 h followed by RT-qPCR. For each gene, relative mRNA levels were determined using 18S
as the reference gene. The fold change in expression upon SETX depletion in hypoxia as compared to the control siRNA in hypoxia are shown. Genes in red
were repressed in SETX-depleted hypoxic cells, while genes in blue were induced, according to the RNA-seq results. The dotted line indicates no change in
expression upon SETX depletion. Data from three independent experiments (n= 3), mean ± standard error of the mean (SEM) are displayed. Two-tailed
Student’s t-test was used: SETX (p < 0.0001), TCF19 (p= 0.0066), GHITM (p= 0.0017), FAM222A (p= 0.0128), ZNF367 (p= 0.0305), MMP1 (p=
0.0135), JUN (p= 0.0006), TM4SF (p= 0.0331), GDF15 (p= 0.0002). d R-loop forming sequence (RLFS) density measured as RLFS per kb of gene length
(upper panel) and % coverage of gene by RLFS (lower panel). The genome plot represents one random sample of all protein-coding genes (n= 500).
Centre line=median; upper and lower bounds of box= 75th and 25th percentiles (3rd and 1st quartiles); upper and lower bounds of the whiskers= 1.5
times the interquartile range from the corresponding ‘hinge’ where the line originates from the box; minima and maxima are given by the top and bottom of
the overlaid violin plot. n= 500 represents the number of protein-coding genes randomly selected to create the null genome distribution shown in light
blue. The SETX up and SETX down violin plots used all of the differentially expressed in the corresponding group. Two-tailed Student’s t-test was used: p-
value= ****= 2.2 × 10−16. e Resampling of RLFS densities used to calculate p-values shown in d. Black vertical lines represent the mean of each
distribution.
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Fig. 3 Accumulation of R-loops in hypoxia (<0.1% O2). a A549 cells were exposed to 21% O2 or <0.1% O2 (shown in green) for 12 h, fixed and stained
with the S9.6 antibody and DAPI. Where indicated, coverslips were treated with RNase H prior to staining. Data from three independent experiments (n=
3) where each dot represents a cell and a minimum of 100 cells were imaged per treatment. One-way ANOVA Tukey’s multiple comparisons test was
used, ****p < 0.0001. b Representative images from a (scale bar: 5 μm). A dashed white line indicates a nuclear outline based on a DAPI stain that was
used to measure the nuclear S9.6 intensity. c A549 cells were transfected with RNase HID210NV5 and exposed to hypoxia (<0.1% O2), CPT (10 µM, 20
min), or DRB (100 µM, 1 h). Staining for V5 was then carried out and the nuclear intensity determined. The two-tailed Student’s t-test was used: ****p <
0.0001. d Representative images from part c are shown (scale bar: 30 μm). V5 staining is green, DAPI to show the nucleus is blue. e HCT116 cells were
transfected with mock or RNase H1 plasmid and exposed to 21% O2 or <0.1% O2 for 6 h. RNase H1 overexpression was confirmed by western blot analysis.
Changes in chromatin modifications H3K9me2, H3K9me3, H3-S10, H3K4me2, H3K36me3, and H3K9Ac are shown. Total H3 was included as a loading
control. f HCT116 cells were treated as in part e (<0.1% O2 for 6 h). The levels of RPA-S4/8 and Chk1-S317 are shown. RPA, Chk1, and β-actin controls were
included. g HCT116 cells transfected with mock or RNase H1 plasmid and exposed to 21% O2 (Norm) or <0.1% O2 (Hyp) for 6 h were stained for RPA and
the % of cells with >5 RPA foci determined. Two-tailed Student’s t-test was used: p= 0.0142. hWestern blotting was carried out on cells treated as in part
g. ATM activation was detected using KAP1-S824, p53-S15, and γH2AX. Total KAP1, p53, H3 and β-actin control westerns were included. a–h Data from
three independent experiments (n= 3), mean ± standard error of the mean (SEM) are displayed unless otherwise indicated.
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cells experiencing replication stress as measured by those with
RPA foci when PERK was lost and found that the percentage of
cells experiencing replication stress in hypoxia did not change
with PERK depletion (Supplementary Fig. 7f). This was not
entirely surprising as cells exposed to hypoxia (<0.1% O2)
demonstrate high levels of replication stress due to reduced dNTP
levels. However, it was apparent that the cells with reduced PERK
activity had increased numbers of RPA foci per cell in hypoxia
suggesting again that hypoxia cells with reduced PERK activity
have increased levels of replication stress (Fig. 6f, g and
Supplementary Fig. 7g). Finally, we tested whether PERK
inhibition led to increased replication stress in hypoxia using
the DNA fibre assay. Inhibition of PERK led to decreased
replication rates in both normoxia and hypoxia, suggesting that
PERK signalling acts to alleviate replication stress (Fig. 6h). Taken
together, our data suggest that in hypoxia, the PERK branch of
Fig. 4 SETX reduces R-loops and protects from DNA damage and cell death in hypoxia. a A549 cells that were either mock-transfected (grey) or
transfected with SETX siRNA (green), were exposed to 21% O2 or <0.1% O2 for 12 h. Cells were fixed and stained with the S9.6 antibody and DAPI. Where
indicated, coverslips were treated with RNase H prior to staining. Data from one independent experiment (n= 1) where each dot represents a cell and a
minimum of 100 cells were imaged per treatment. b Replication rates, as determined by IdU incorporation rates, of RKO cells transfected with control
siRNA versus SETX siRNA exposed to 21% O2 (Norm) or <0.1% O2 (Hyp) for 6 h. Data from three independent experiments (n= 3) where each dot
represents a fibre and a minimum of 100 fibres were analysed per treatment. Two-tailed Mann–Whitney U test was used: ****p < 0.0001, *p= 0.0068. c
Percentage of cells displaying 53BP1 foci (>5 per nucleus) in RKO cells with either mock-treated or treated with SETX siRNA. Cells were exposed to 21% O2
(Norm), 6 h of <0.1% O2 (Hyp) or pre-treated with DRB (100 µM) followed by 6 h of <0.1% O2 (Hyp+DRB). One-way ANOVA Tukey’s multiple
comparisons test was used: nsp= 0.1240, **p= 0.0046, ****p < 0.0001. d A549 cells that were either mock-transfected (grey) or transfected with SETX
siRNA (green) were pulsed with EdU (10 µM) for 1 h then and exposed to 21% O2 (Norm), <0.1% O2 (Hyp) for 6 h or treated with DRB (100 µM) in <0.1%
O2 for 6 h (Hyp+DRB). The percentage of cells displaying 53BP1 (>5 per nucleus) is shown. Two-tailed Student’s t-test was used: ****p≤ 0.0001. e
Colony survival of A549 cells with either mock treatment or SETX siRNA after 0 and 18 h of hypoxia (Hyp) (<0.1% O2) treatment. Two-tailed Student’s t-
test was used: p= 0.0065. f A549 cells were mock-treated or treated with SETX siRNA and exposed to 21% O2 (Norm), <0.1% O2 (Hyp) for 24 h or pre-
treated with DRB (100 µM) followed by 24 h of <0.1% O2 (Hyp+DRB). The percentage of cells positive for cleaved caspase 3 (Cl. Casp3) is shown.
Representative images of a normal and apoptotic cell are included (scale bar: 5 μm). One-way ANOVA Tukey’s multiple comparisons test was used: Hyp
Mock versus Hyp siSETX (**p= 0.0035), Hyp siSETX versus Hyp+ DRB siSETX (**p= 0.0020). a–f Data from three independent experiments (n= 3),
mean ± SEM are displayed unless otherwise indicated. Source data for d is provided as a Source Data file.
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the UPR signals through SETX and potentially other unidentified
factors to reduce R-loops, replication stress, DNA damage and
apoptosis (Fig. 6i).
Discussion
Our study suggests that R-loops accumulate in response to
hypoxia and that this biological response includes induction of
the RNA/DNA helicase SETX. Hypoxia-induced SETX reduces
replication stress and protects hypoxic cells from transcription-
associated DNA damage and apoptosis. Importantly, SETX
induction is dependent on the PERK branch of the UPR. PERK
inhibition increased R-loops and replication stress, uncovering an
entirely novel aspect of PERK function in hypoxia.
The accumulation of R-loops in hypoxia may act as a signal of
transcriptional stress to the cell, leading to a further cascade of
stress-response signalling pathways. R-loops have previously been
shown to activate non-canonical ATM signalling through spli-
ceosomal displacement57. Our data show that by reducing R-
loops through the overexpression of RNase H1 in hypoxia, both
the DDR and replication stress responses are alleviated. The
reduction in replication stress in hypoxia upon RNase H1 over-
expression could be due to less R-loops forming barriers to
replication fork progression58. Together, these data highlight
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transcriptional stress as an additional signal to nucleotide
depletion in the induction of ATM/ATR signalling in hypoxia. R-
loops are therefore implicated as making a significant contribu-
tion to the biological response to hypoxia.
While the DDR and UPR are both active in hypoxia, the DDR
is restricted to S phase cells5. The UPR/PERK dependency of
SETX induction ensures that cells in all phases of the cell cycle
increase SETX levels in hypoxia. Combined with our findings
using an inhibitor of transcription, this suggests a role for SETX
in resolving co-transcriptional R-loops. We hypothesise that these
hypoxia-induced R-loops occur at stress-responsive genes which
are induced in response to hypoxia, for example, HIF targets.
Previous reports have demonstrated that an accumulation of R-
loops can lead to an increase in DNA damage. However, hypoxia
does not lead to an accumulation of DNA damage even after
extended periods of time, suggesting that the hypoxia-induced R-
loops are distinct to those induced by other genotoxic stresses
such as camptothecin and G-quadruplex ligands59,60. The DNA
damage we observed in SETX-depleted hypoxic cells is tran-
scription-dependent, supporting the hypothesis that the role of
hypoxia-induced SETX is to resolve the co-transcriptional R-
loops that are prone to DNA damage and therefore reduce
genomic instability.
Lending support to our finding that SETX is induced by the
UPR in hypoxia, RNA-sequencing showed that SETX knockdown
led to increased transcription of rRNA processing, nucleolar and
ribosome biogenesis genes in hypoxia. Given that the UPR is
known to inhibit rRNA transcription and protein translation, it is
possible that one of the mechanisms that contribute to these
functions of the UPR is through the induction of SETX. A role for
SETX in hypoxia-induced UPR-mediated repression of rRNA and
translation warrants further investigation.
Interestingly, a previous report showed that in response to a
short exposure (1 h) of thapsigargin or DTT, PERK inhibits
replication fork progression, and origin firing through a Claspin/
Chk1 pathway61. While it is challenging to interpret these see-
mingly contradictory findings with those presented here, this does
further support a role for the UPR in replication stress. Differ-
ences likely arise from the use of chemically induced UPR sig-
nalling and the hypoxia-induced UPR and the timeframe of the
experiments carried out62.
SETX has been identified as a potential tumour suppressor63
and in support of this, SETX expression was found to be reduced
in a number of cancers compared to normal tissue controls43.
However, AOA2 patients do not present with increased cancer
susceptibility suggesting a level of redundancy with other R-loop
resolution mechanisms exists to protect genome stability. In this
study, SETX depletion increased R-loops, replication stress, DNA
damage and apoptosis in hypoxia suggesting that SETX may
promote hypoxic tumour growth, and hence be a potential
therapeutic target. Interestingly, SETX was recently identified as a
gene whose knockout increases sensitivity to cisplatin in a set of
genome-wide CRISPR-Cas9 screens64. It is possible that in the
hypoxic microenvironment in which multiple pathways including
DNA repair and potentially R-loop resolution factors are
repressed, loss of SETX function would not be readily compen-
sated by other mechanisms in a manner similar to its deficiency
in the cerebellum. In addition, this study demonstrates that
inhibiting PERK leads to increased R-loops, DNA damage and
replication stress in hypoxia, and therefore PERK could also be a
potential therapeutic target. Targeting PERK in cancer has been
controversial as PERK has demonstrated both tumours promot-
ing and suppressive activities depending on the type of cancer and
intensity of stress65. However, in hypoxia, PERK supports tumour
survival and growth, therefore suggesting PERK as a potential
therapeutic target specifically for hypoxic tumours66,67. Since
PERK inhibition also increased replication stress in hypoxic
conditions, we postulate that using PERK inhibitors in conjunc-
tion with replication stress inducers such as ATR inhibitors may
be beneficial in solid tumours.
Methods
Cell lines and reagents. RKO, HCT116 and A549 (ATCC) were grown in DMEM
supplemented with 10% FBS and cultured in humidified incubators at 37 °C and
5% CO2. Cells were routinely tested for mycoplasma and found to be negative. For
plasmid transfections, JetPrime (Polyplus transfection) was used. ppyCAG_RNa-
seH1_WT (#111906) and ppyCAG_RNaseH1_D210N (#111904) were supplied by
Addgene. siRNA transfections were performed using Dharma-FECT-1 (Thermo-
Fisher Scientific), sequences are available in the SI. siSETX-A siRNA was used for
Figs. 2d–f, 3b and Supplementary Figs. 2D–G, 3, 4, 5A, G. siSETX-B siRNA was
used for Figs. 2c, 3a, c–f and Supplementary Figs. 2B, C and 5F. AllStars negative
control siRNA (Qiagen) and ON-TARGETplus non-targeting pool (Dharmacon)
were used as control siRNA. Specific siRNA sequences are shown in Supplementary
Table S2. Drugs used were the radiomimetic neocarzinostatin (NCS), DRB,
Camptothecin (CPT), Hydroxyurea, hypoxia mimetic DFO, Adriamycin (Sigma),
tunicamycin and thapsigargin (MP Biomedicals), and PERK inhibitor GSK2606414
(Calbiochem). Irradiations were performed using a Gamma Service GSR D1 Cs137
irradiator.
Hypoxia treatment. Bactron II and BactronEZ anaerobic chambers (Shel Lab)
were used for <0.1% O2. An M35 hypoxia work station (Don Whitley Ltd) was
used for 2% O2. All experiments at <0.1% O2 were plated in glass dishes, except for
colony survival assays, which were plated in 6 well plates. All hypoxic treatments
were harvested within the chamber using equilibrated buffers. Oxygen tensions
were confirmed with the Oxylite probe (Oxford Optronix).
Immunoblotting. Cells were harvested in UTB lysis buffer (9 M Urea, 75 mM Tris-
HCl pH 7.5, 0.15 M β-mercaptoethanol). Blots were visualised using the Odyssey
Infrared imaging system. Antibodies used were SETX, KAP1 (Bethyl); GRP78,
HIF1α, (ΒD Biosciences); ATM-S1981, RPA-S4/8, β-Tubulin (Abcam); ATM, RPA,
KAP1-S824, p53-S15, H3K9me2, H3K4me2, H3K9Ac, H3-S10, H3, H3K36me3,
Chk1-S317, PERK (Cell Signaling); p53, β-actin, RNase H1, Chk1 (Santa Cruz);
and H3K9me3, γH2AX, H2AX (Millipore).
Fig. 5 SETX upregulation is dependent on the PERK branch of the UPR. a A549 cells were treated with either control siRNA or p53 siRNA and exposed to
21% O2 (Norm) or <0.1% O2 (Hyp) for 6 h. SETX mRNA levels were determined by RT-qPCR. One-way ANOVA Tukey’s multiple comparisons test was
used: nsp= 0.9996, **p= 0.0050. b A549 cells were treated with either control siRNA or ATF4 siRNA and exposed to 21% O2 (Norm) or <0.1% O2 (Hyp)
for 16 h. SETX mRNA levels were determined by RT-qPCR. One-way ANOVA Tukey’s multiple comparisons test was used: **p= 0.0023. c A549 cells were
exposed to 21% O2 (Norm) or <0.1% O2 (Hyp) for 4 h, and ChIP-qPCR experiments were performed to determine fold enrichment of ATF4 at the SETX
promoter relative to IgG control. One-way ANOVA Tukey’s multiple comparisons test was used: *p= 0.0416. d SETX mRNA levels in non-treated A549
cells (Norm), Hu (1 mM), <0.1% O2 (Hyp), tunicamycin (Tuni, 5 µg/mL) or thapsigargin (Thaps, 2 µM) for 16 h. One-way ANOVA Dunnett’s multiple
comparisons test was used: ****p < 0.0001. e A549 cells were exposed to Thapsigargin (Thaps) (2 µM) or Tunicamycin (Tuni) (5 µg/mL) for the times
indicated, or to Hu (2 mM, 8 h) followed by western blotting. f Percentage of cells displaying RPA foci (>5 per nucleus) in A549 control or Hu (2 mM)
treated cells that were also treated with or without Thaps (2 µM) for 24 h. The two-tailed Student’s t-test was used: ****p < 0.0001. g Representative
images from f (scale bar: 5 μm). h A549 control or Hu (2 mM) treated cells were also treated with or without Thaps (2 µM) for 24 h followed by western
blotting. β-actin was used as the loading control. i A549 control or Hu (2 mM) treated cells were also treated with DMSO, Tuni (5 µg/mL), Thaps (2 µM)
or Thaps (2 µM) and PERKi (10 μM) for 24 h followed by western blotting. β-actin was used as the loading control. a–i Data from three independent
experiments (n= 3), mean ± SEM are displayed unless otherwise indicated.
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RT-qPCR. RNA was extracted using TRI reagent (Sigma), treated with DNase I
(NEB) and cDNA prepared using the Verso cDNA synthesis kit (Thermo-
Scientific). SYBR Green PCR master mix (Applied Biosystems) and 7500 FAST
Real-Time PCR machine (Applied Biosystems) were used. The ΔΔCt method was
used to determine relative mRNA fold change with 18S as the reference gene.
Primer sequences can be found in Table S1.
Chromatin immunoprecipitation (ChIP) - qPCR. Treated cells were fixed with
1% formaldehyde and quenched in 125 mM glycine. Cells were lysed with SDS
lysis buffer (0.5% SDS, 10 mM EDTA, 50 mM tris pH 8.1). After sonication with
Diagenode Bioruptor, samples were precleared with protein A agarose beads
and subsequently incubated with ATF4 antibody (Cell Signaling) overnight.
Antibody–antigen complexes were then pulled down with agarose beads and
washed with the following buffers—low salt wash buffer (0.1% SDS, 1% Triton-X
100, 2 mM EDTA, 20 mM Tris pH 8.1, 150 mM NaCl), high salt wash (0.1% SDS,
1% Triton-X 100, 2 mM EDTA, 20 mM Tris pH 8.1, 500 mM NaCl), LiCl wash
buffer (1% Igepal, 10 mM Tris pH 8.1, 250 mM LiCl, 1 mM EDTA, 1% sodium
deoxycholate), TE wash buffer (10 mM Tris pH 8.0, 1 mM EDTA). DNA was
eluted with 0.1 M NaHCO3 and 1% SDS, cross-linking reversed and treated with
proteinase K. DNA was purified with Qiagen PCR purification kits and qPCR
was carried out using the following primers: SETX For: CTCAGGTGTCT-
CAGCGGATG, SETX Rev: CGCATTGTTCGCAAGACCTA, CHOP For: AAG
AGGCTCACGACCGACTA and CHOP Rev: ATGATGCAATGTTTGGCAAC.
The amount of immunoprecipitated material was calculated as the fold
enrichment over IgG control.
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Immunofluorescence and confocal microscopy. Cells were fixed in 4% (w/v)
paraformaldehyde in PBS, permeabilised in 1% Triton-X 100 in PBS and blocked
with 2% (w/v) BSA in 0.1% Tween-20 in PBS. Primary antibodies 53BP1 (Novus
Biologicals), RPA (Cell Signaling) and cleaved caspase 3 (Cell Signaling) were
used. For 5′EU staining, cells were incubated with 5′ethynyluridine (EU) (0.5
mM) (Jena Bioscience) and Click-iT Alexa Fluor 647 labelling kit (ThermoFisher)
was used to measure nascent transcription in the entire nucleus. For EdU
staining, cells were incubated with EdU (10 µM) and Click-iT Alexa Fluor 647
labelling kit (ThermoFisher) was used to measure replication. The S9.6 staining
protocol used was as previously described14. Coverslips were treated with RNase
A (Fermentas) for 1 h at 37 °C and where indicated with RNase H (NEB) for 24 h
at 37 °C prior to blocking. Coverslips were then incubated with 1:100 diluted S9.6
antibody (Kerafast) for 36 h at 4 °C. Cells were mounted and the entire nucleus
imaged using LSM780 or LSM710 confocal microscope (Carl Zeiss, Germany),
using a ×63/1.40 Oil DIC M27 Plan-ApoChromat objective. Detection of R-loops
using RNase H1D210N-V5 was carried out as previously described68. In brief, cells
transfected with RNase H1D210N-V5 were pre-extracted in ice-cold PBS/0.2%
Triton-X 100 for 2 min, fixed in 4% (w/v) paraformaldehyde, permeabilised in
0.1% Triton-X 100, blocked with 1% (w/v) BSA in 1% (w/v) FBS in PBS, incu-
bated with 1:500 diluted V5 antibody (ThermoFisher Scientific) for 1 h at room
temperature before confocal imaging. DAPI was excited with laser line 405 nm
and emission collected between 410 and 495 nm. Alexa-fluor 488 was excited with
laser line 488 nm and emission collected between 495 and 596 nm. Alexa-fluor
594 was excited with laser line 594 nm and emission collected between 599 and
734 nm. Alexa-fluor 647 was excited with laser line 633 nm and emission col-
lected between 638 and 755 nm. The 5′EU, S9.6 and V5 mean nuclear intensity
signal (including the nucleolus) was determined using the ImageJ plugin/algo-
rithm kindly provided by Dr Kienan Savage, Queen’s University Belfast69. A
minimum of 100 cells was included per treatment.
RNA-seq. RNA was extracted using TRI reagent (Sigma) and treated with DNase I
(NEB). The samples were purified using the RNeasy MinElute Clean-up kit
(Qiagen) and purity confirmed using a Bioanalyzer. The mRNA fraction was
selected for reverse transcription to cDNA. The cDNA generated was end-repaired,
A-tailed and adaptor-ligated. cDNA libraries were size selected, multiplexed, tested
for quality and subjected to paired-end sequencing in one lane of a flow cell.
Accession for RNA-seq data is GSE157371.
RNA-seq differential expression analysis. The analyses were run through an
established RNA-seq pipeline by the Buffa lab. The technical adaptors in the pair-
end raw reads were trimmed out by trimmomatic-0.32 and the clear reads were
aligned to human genome version GRCh38 release 82 using tophat v2.0.13. The
mapped reads from each gene were counted and normalised to fragments per
kilobase of transcript per million (FPKM) using Cuffdiff-2.2.1. Fragments from
PCR duplication were removed by Picard 1.124. The significance of fold changes of
genes among samples was estimated by the nonparametric method Rank Product
3.3, a package in R70–75.
Correlation of SETX expression with TCGA RNA-seq data. RNA-seq data (RNA
Seq V2 RSEM) for 382 colorectal adenocarcinoma tumours, 501 lung squamous
cell carcinomas and 517 lung adenocarcinomas were downloaded from the TCGA
project (accessed through cBioportal: http://www.cbioportal.org/ on the 12th April
2017). To examine SETX expression against hypoxia, a validated hypoxia metagene
signature was used44. To examine SETX expression against tumour-associated,
hypoxia-induced p53 activity (referred to as hypoxic p53 targets in the figure), raw
data for each sequenced gene were rescaled to set the median equal to 1, and
hypoxic p53 targets were determined by quantifying the median expression of 6
p53 target genes associated with hypoxia-induced p53 activity (encoding BTG2,
CYFIP2, INPP5D, KANK3, PHLDA3, and SULF2)25.
Prediction of RLFS sequences. The quantitative model of R-loop forming
sequences (qm-RLFS) was used to predict RLFS from fasta files of the human
genome build GRCh38.p13 (accessed from https://www.gencodegenes.org/human/
on 23rd March 2020) using default settings. Bedtools76 was used to merge RLFS
with at least 1 base pair overlap and these merged regions were used for subsequent
analysis.
Gene coordinates were accessed via BiomaRt using the Ensembl hg38 build
version 10077 and tested for overlaps with the coordinates of genes in the up and
downregulated groups. Two kb flanks were added at the transcription start
transcription termination sites to include promoter and terminator regions
respectively. Only co-transcriptional RLFS were assessed. Custom R scripts were
then used to quantify and plot RLFS per kilobase of gene length and per cent of a
gene covered by RLFS. For senataxin knockdown vs. genome comparisons, each set
of genes (up or downregulated by SETX KD vs. all protein-coding genes) was
sampled 100,000 times, drawing 20% of the number of genes in the SETX KD
group with each iteration. The mean of each RLFS metric was calculated for each
iteration and the values plotted as probability densities and compared using two-
tailed Student’s t-tests.
DNA fibre analysis. For normoxic (21% O2) treatments, cells were pulse-labelled
with CldU (25 mM) for 20 min, washed once with fresh media, followed by the
second label IdU (250 mM) for 20 min. For hypoxic (<0.1% O2) treatments, cells
were incubated in hypoxia for 3 h before being pulse-labelled with CldU (25 mM)
for 2 h, washed once with fresh media, then followed by IdU (250 mM) for 1 h78.
Fibres were spread, stained and mounted (Invitrogen) and imaged using LSM780
confocal microscope (Carl Zeiss Microscopy Ltd) using a ×63/1.40 Oil DIC M27
Plan-ApoChromat objective. Alexa-fluor 488 was excited with laser line 488 nm
and emission collected between 493 and 551 nm. Alexa-fluor 555 was excited with
laser line 543 nm and emission collected between 559 and 659 nm. Replication
rates were calculated as VldU (kb/min)= [(x ∗ 0.132 μm) ∗ 2.59 kb/μm]/t (min),
where x= length of IdU.
Statistical analysis. Statistical tests were performed using GraphPad Prism soft-
ware (GraphPad Software Inc.) and include one-way ANOVA, two-way ANOVA,
two-tailed Student’s t-test and Mann–Whitney U tests. ns= non-significant, *p ≤
0.05, **p ≤ 0.01, ***p ≤ 0.001, ****p ≤ 0.0001.
Reporting summary. Further information on research design is available in the Nature
Research Reporting Summary linked to this article.
Data availability
The sequencing data that support the findings reported in this study have been deposited
in the National Center for Biotechnology Information Gene Expression Omnibus (GEO)
Fig. 6 Hypoxia links the UPR with replication stress. a A549 cells were treated with either control siRNA or PERK siRNA and exposed to 21% O2 (Norm)
or <0.1% O2 (Hyp) for 16 h. SETX mRNA levels were determined by RT-qPCR. One-way ANOVA Tukey’s multiple comparisons test was used: ****p <
0.0001. b A549 cells were treated with or without PERKi (10 µM) and exposed to DMSO or Thaps (2 µM) for 6 h. SETX mRNA levels were determined by
RT-qPCR. One-way ANOVA Tukey’s multiple comparisons test was used: ***p= 0.0003. c A549 cells were either mock-treated or treated with PERK
siRNA, transfected with RNase HID210NV5 and exposed to hypoxia (<0.1% O2), CPT (10 µM, 20min) or DRB (100 µM, 1 h). Staining for V5 was then
carried out and the nuclear intensity determined. The two-tailed Student’s t-test was used: ****p < 0.0001. d The percentage of cells displaying 53BP1 foci
(>5 per nucleus) as determined by immunofluorescence, in A549 cells exposed to 21% O2 (Norm) or 6 h of <0.1% O2 (Hyp). Cells were treated with
DMSO, PERKi (10 µM), or DRB (100 µM) and PERKi (10 µM) (PERKi+DRB). The two-tailed Student’s t-test was used: Norm PERKi versus Hyp PERKi (**p
= 0.0067), Hyp+ PERKi versus Hyp+ PERKi+DRB (**p= 0.0068). e A549 cells were treated with DMSO or PERKi (10 µM) and exposed to normoxia or
hypoxia (<0.1% O2) for 6 h followed by western blotting as indicated. PERK inhibition was confirmed by the absence in the electrophoretic mobility shift of
PERK on the western blot. f A549 cells with either mock treatment or PERK siRNA were exposed to hypoxia (<0.1% O2) for 6 h, cells were fixed and
stained for RPA by immunofluorescence assays. Representative images are shown (scale bar: 5 μm). g Quantification of the number of RPA foci per cell
from f. Treatment with siRNA PERK is indicated in green. Data from two independent experiments (n= 2) where each dot represents a cell and a minimum
of 100 cells were imaged per treatment. Two-tailed Mann–Whitney U test was used: **p= 0.0024. h Replication rates, as determined by IdU incorporation
rates, of A549 cells treated with DMSO or PERKi (10 µM) and exposed to 21% O2 (Norm) or <0.1% O2 (Hyp) for 6 h. Data from two independent
experiments (n= 2) where each dot represents a fibre and a minimum of 100 fibres were analysed per treatment. Two-tailed Mann–Whitney U test was
used: ****p < 0.0001. i Hypoxia leads to the activation of the UPR and replication stress. In addition to a shortage of nucleotides, R-loops accumulate in
hypoxia and contribute to replication stress. The PERK branch of the UPR signals through ATF4 to increase SETX expression in hypoxia. Hypoxia-induced
SETX reduces R-loop accumulation and subsequent replication stress-mediated signalling. a–h Data from three independent experiments (n= 3), mean ±
SEM are displayed unless otherwise indicated.
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and are accessible through the GEO Series accession number GSE157371. All other
relevant data are available from the corresponding author upon request. Source data are
provided with this paper.
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